Table 4.
Assay and targeta | LOD range |
Unit of measureb | Fold decrease in TLDA LOD | |
---|---|---|---|---|
IRTP assay | TLDA | |||
Flu A | ||||
Template A | 0.6–6 | 6–60 | EID50/ml (H1) | 10 |
Template B | 6–60 | 60–600 | EID50/ml (H3) | 10 |
Flu A–H1 | 0.6–6 | 6–60 | EID50/ml | 10 |
Flu A–H3 | 6–60 | 60–600 | EID50/ml | 10 |
Flu B | 0.6–6 | 6–60 | EID50/ml | 10 |
RSV | 0.6–6 | 60–600 | Transcripts/μl | 100 |
HPIV1 | 60–600 | 600–6000 | Transcripts/μl | 10 |
HPIV2 | 6–60 | 6–60 | Transcripts/μl | 1 |
HPIV3 | 6–60 | 60–600 | Transcripts/μl | 10 |
HMPV | 600–6000 | 600–6000 | Transcripts/μl | 1 |
RV | 0.6–6 | 6–60 | Transcripts/μl | 10 |
EV | 6–60 | 60–600 | Transcripts/μl | 10 |
HPeV | 0.6–6 | 6–60 | Transcripts/μl | 10 |
Pan-AdV | ||||
AV11 | 0.6–6 | 6–60 | GE/μl (AV11) | 10 |
AV15 | 6–60 | 600–6000 | GE/μl (AV15) | 100 |
Pan-Legionella spp. | 0.06–0.6 | 0.6–6 | GE/μl | 10 |
L. pneu | 0.06–0.6 | 0.6–6 | GE/μl | 10 |
H. influ | 0.6–6 | 0.6–6 | GE/μl | 1 |
S. pneumo | 0.6–6 | 6–60 | GE/μl | 10 |
S. pyo | 6–60 | 60–600 | GE/μl | 10 |
M. pneumo | 0.06–0.6 | 0.6–6 | GE/μl | 10 |
C. pneumo | 0.04–0.4 | 4–40 | IFU/ml | 100 |
B. pert I | 6–60 | 6–60 | GE/μl | 1 |
B. pert II | 6–60 | 6–60 | GE/μl | 1 |
Flu A, influenza virus type A; Flu A–H1, influenza virus type A subtype H1; RSV, respiratory syncytial virus; HPIV1, human parainfluenza virus type 1; HMPV, human metapneumovirus; RV, rhinovirus; EV, enterovirus; HPeV, human parechovirus; pan-AdV, pan-adenovirus; AV11, adenovirus 11; L. pneu, Legionella pneumophila; H. influ, Haemophilus influenzae; S. pneumo, Streptococcus pneumoniae; S. pyo, Streptococcus pyogenes; M. pneumo, Mycoplasma pneumoniae; C. pneumo, Chlamydophila pneumoniae; B. pert I, Bordetella pertussis target I.
EID50, 50% egg infectious dose; GE, genome equivalents; IFU, inclusion-forming units.